Sign in

NCT04061148Recruiting

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

Clinical Testing of Near Infrared Spectroscopy (NIRS) for Quantitative Assessment of Depression

Source: ClinicalTrials.gov · Last updated 11 Sept 2026

Brief summary (registry, in English)

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
20 Feb 2019
Start date
4 Jan 2019
Primary completion date
30 Dec 2029
Lead sponsor
University of California, San Francisco
Diseases
Depression
NCT number
NCT04061148

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From 4 Jan 2019 to the primary completion date, 30 Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Exclusion criteria for depressed patients: 1.Psychotic disorders like schizophrenia 2.Major neurocognitive disorders such as Alzheimer's disease and other dementias 3.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation 4.Not receiving clinical therapy for depression at SFVAMC'

Other illness

  • Exclusion criteria for control subjects: 1.Depression 2.Anxiety, psychotic, substance abuse, mood and personality disorders 3.Major neurocognitive disorders such as Alzheimer's disease and other dementias 4.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation

Other

  • Subjects who cannot sign informed consent.

Who the study is looking for

  • All subjects who sign informed consent.
  • Controls: Volunteers over 18 years of age who are not depressed.
  • Patients over 18 years of age with a diagnosis of Major Depressive Disorder, receiving clinical therapy at SFVAMC.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
San Francisco Veterans Affairs Medical Center
Coordinator of this site? Confirm its status
San FranciscoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.